D68.3 - Hemorrhagic disorder due to circulating anticoagulants
D68.31 - Hemorrhagic disorder due to intrinsic circulating anticoagulants, antibodies, or inhibitors
D68.312 - Antiphospholipid antibody with hemorrhagic disorder
InclusionTerm:
-Lupus anticoagulant (LAC) with hemorrhagic disorder
-Systemic lupus erythematosus [SLE] inhibitor with hemorrhagic disorder
Excludes 1:
-antiphospholipid antibody, finding without diagnosis R76.0)
-antiphospholipid antibody syndrome D68.61)
-antiphospholipid antibody with hypercoagulable state D68.61)
-lupus anticoagulant (LAC) finding without diagnosis R76.0)
-lupus anticoagulant (LAC) with hypercoagulable state D68.62)
-systemic lupus erythematosus [SLE] inhibitor finding without diagnosis R76.0)
-systemic lupus erythematosus [SLE] inhibitor with hypercoagulable state D68.62)